文献速递慢性肾脏病遗传性与小管间质肾病

TRPC6-钙蛋白酶1轴通过抑制线粒体自噬促进糖尿病肾病小管间质炎症

TRPC6-Calpain-1 Axis Promotes Tubulointerstitial Inflammation by Inhibiting Mitophagy in Diabetic Kidney Disease.
PubMed 文献 · Kidney Int Rep · 2024-08-23

本研究在链脲佐菌素诱导的糖尿病肾病小鼠模型和高糖处理的HK-2细胞中,探究线粒体自噬异常介导小管间质炎症的分子机制。发现TRPC6通过激活钙蛋白酶1抑制PINK1/Parkin通路依赖的线粒体自噬,敲低Trpc6或药物激活线粒体自噬可减轻小管损伤和间质炎症,BAPTA或calpeptin可阻断该效应。结论提示TRPC6-钙蛋白酶1轴是潜在干预靶点。

要点

  • 糖尿病肾病中小管间质炎症与PINK1/Parkin通路介导的线粒体自噬抑制相关。
  • TRPC6通过激活钙蛋白酶1抑制线粒体自噬,敲低Trpc6可减轻小管损伤和炎症。
  • 药物激活线粒体自噬或抑制钙蛋白酶1可阻断TRPC6介导的线粒体自噬抑制。

核心结论

  • TRPC6-钙蛋白酶1轴通过抑制线粒体自噬促进糖尿病肾病小管间质炎症。

研究设计与样本

  • 建立链脲佐菌素诱导的糖尿病肾病小鼠模型,并以高糖处理的HK-2细胞作为体外模型。
  • 通过药物urolithin A调控小管线粒体自噬,采用体内外遗传干预探索TRPC6的功能效应。

主要发现

  • 糖尿病肾病中小管间质炎症与线粒体自噬抑制密切相关,该抑制由PINK1/Parkin通路紊乱介导。
  • 激活线粒体自噬可显著减轻小管损伤和小管间质炎症。
  • TRPC6在糖尿病肾病中显著增加,通过激活钙蛋白酶1抑制线粒体自噬。
  • 敲低Trpc6可部分逆转线粒体自噬异常,并在体内外减轻小管损伤和小管间质炎症。
  • BAPTA(特异性Ca2+螯合剂)或calpeptin(特异性钙蛋白酶1抑制剂)可阻断小管TRPC6介导的线粒体自噬抑制。

临床怎么用

  • 靶向TRPC6-钙蛋白酶1轴或激活线粒体自噬可能成为减轻糖尿病肾病小管间质炎症的策略。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Renal tubulointerstitial inflammation represents an effective indicator for predicting the progression of diabetic kidney disease (DKD). Mitophagy abnormality is 1 of the most important factors involved in tubule injury. However, the exact molecular mechanism underlying mitophagy abnormality-mediated tubulointerstitial inflammation in DKD remains poorly understood. METHODS: In this study, a streptozotocin-induced DKD mouse model was established and HK-2 cells treated with high glucose (HG) served as an in vitro model. Tubular mitophagy was regulated through pharmacological urolithin A (UA) administration. The functional effect of the transient receptor potential cation channel, subfamily C, member 6 (TRPC6) was explored using genetic interventions in vivo and in vitro. RESULTS: We found that renal tubulointerstitial inflammation in DKD was closely associated with mitophagy inhibition, which was mediated by disturbance of PINK1/Parkin pathway. Mitophagy activation significantly attenuated tubular injury and tubulointerstitial inflammation. Further, it was found that TRPC6 was markedly increased in DKD and played an essential role in mitophagy inhibition by activating calpain-1. Knockdown of Trpc6 partially reversed mitophagy abnormality and consequently attenuated tubular injury and tubulointerstitial inflammation in vivo and in vitro. Finally, we found that tubular TRPC6-mediated mitophagy inhibition was blocked with BAPTA (a specific Ca2+ chelator) or calpeptin (a specific calpain-1 inhibitor). CONCLUSION: Our study reveals that TRPC6-calpain-1 axis promotes tubulointerstitial inflammation in DKD by inhibiting mitophagy.

来源:Kidney Int Rep,查看原文。版权归原作者所有。

引用

  1. Liu CC, Ji JL, Wang Z, et al. TRPC6-Calpain-1 Axis Promotes Tubulointerstitial Inflammation by Inhibiting Mitophagy in Diabetic Kidney Disease. Kidney Int Rep. 2024. PMID: 39534194. doi:10.1016/j.ekir.2024.08.019

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。